5 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp08058 | TAT-327 | RKKRRQRRREFLDCFQKF | Peptide-327 | Peptide 327 blocks Eps8–EGFR | CCK-8 assay | A-549 | Lung Cancer | EC50 = 55.42 ± 0.84 μM |
| dbacp08059 | TAT-327 | RKKRRQRRREFLDCFQKF | Peptide-327 | Peptide 327 blocks Eps8–EGFR | CCK-8 assay | HepG-2 | Liver Cancer | EC50 = 68.52 ± 2.96 μM |
| dbacp08060 | TAT-327 | RKKRRQRRREFLDCFQKF | Peptide-327 | Peptide 327 blocks Eps8–EGFR | CCK-8 assay | Colo-320 | Colon Cancer | EC50 = 68.40 ± 0.42 μM |
| dbacp08061 | TAT-327 | RKKRRQRRREFLDCFQKF | Peptide-327 | Peptide 327 blocks Eps8–EGFR | CCK-8 assay | HT-29 | Colon Cancer | EC50 = 74.08 ± 0.63 μM |
| dbacp08062 | TAT-327 | RKKRRQRRREFLDCFQKF | Peptide-327 | Peptide 327 blocks Eps8–EGFR | CCK-8 assay | SW-620 | Colorectal Cancer | EC50 = 64.61 ± 1.63 μM |